BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 10649814)

  • 1. Guidelines for the diagnosis and treatment of hyperprolactinemia.
    Biller BM; Luciano A; Crosignani PG; Molitch M; Olive D; Rebar R; Sanfilippo J; Webster J; Zacur H
    J Reprod Med; 1999 Dec; 44(12 Suppl):1075-84. PubMed ID: 10649814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical presentation of hyperprolactinemia.
    Luciano AA
    J Reprod Med; 1999 Dec; 44(12 Suppl):1085-90. PubMed ID: 10649815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic evaluation of hyperprolactinemia.
    Biller BM
    J Reprod Med; 1999 Dec; 44(12 Suppl):1095-9. PubMed ID: 10649817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperprolactinemia: etiology, diagnosis, and management.
    Mah PM; Webster J
    Semin Reprod Med; 2002 Nov; 20(4):365-74. PubMed ID: 12536359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indications for hyperprolactinemia therapy.
    Olive D
    J Reprod Med; 1999 Dec; 44(12 Suppl):1091-4. PubMed ID: 10649816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indications for surgery in the treatment of hyperprolactinemia.
    Zacur HA
    J Reprod Med; 1999 Dec; 44(12 Suppl):1127-31. PubMed ID: 10649823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperprolactinemia: pathophysiology and management.
    Verhelst J; Abs R
    Treat Endocrinol; 2003; 2(1):23-32. PubMed ID: 15871552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of prolactinomas during pregnancy.
    Molitch ME
    J Reprod Med; 1999 Dec; 44(12 Suppl):1121-6. PubMed ID: 10649822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hyperprolactinemia].
    König MP; Kopp P
    Schweiz Med Wochenschr; 1986 Mar; 116(9):265-70. PubMed ID: 3952483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and management of galactorrhea.
    Leung AK; Pacaud D
    Am Fam Physician; 2004 Aug; 70(3):543-50. PubMed ID: 15317441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current diagnosis and treatment of hyperprolactinemia].
    Melgar V; Espinosa E; Sosa E; Rangel MJ; Cuenca D; Ramírez C; Mercado M
    Rev Med Inst Mex Seguro Soc; 2016; 54(1):111-21. PubMed ID: 26820213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperprolactinemia.
    Biller BM
    Int J Fertil Womens Med; 1999; 44(2):74-7. PubMed ID: 10338264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperprolactinaemia in 271 women: up to three decades of clinical follow-up.
    Berinder K; Stackenäs I; Akre O; Hirschberg AL; Hulting AL
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):450-5. PubMed ID: 16181238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperprolactinaemia.
    Prabhakar VK; Davis JR
    Best Pract Res Clin Obstet Gynaecol; 2008 Apr; 22(2):341-53. PubMed ID: 17889620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolactin-secreting tumors: what's new?
    Molitch ME
    Expert Rev Anticancer Ther; 2006 Sep; 6 Suppl 9():S29-35. PubMed ID: 17004854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Reversible blindness caused by an invasive prolactinoma].
    Schöfl-Siegert B; Brabant G; von zur Mühlen A; Schöfl C
    Dtsch Med Wochenschr; 2001 May; 126(21):621-4. PubMed ID: 11413749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine agonist therapy in hyperprolactinemia.
    Webster J
    J Reprod Med; 1999 Dec; 44(12 Suppl):1105-10. PubMed ID: 10649819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of prolactin-secreting macroadenomas with the once-weekly dopamine agonist cabergoline.
    Biller BM; Molitch ME; Vance ML; Cannistraro KB; Davis KR; Simons JA; Schoenfelder JR; Klibanski A
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2338-43. PubMed ID: 8964874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperprolactinemia and prolactinomas.
    Mancini T; Casanueva FF; Giustina A
    Endocrinol Metab Clin North Am; 2008 Mar; 37(1):67-99, viii. PubMed ID: 18226731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrence of hyperprolactinemia following dopamine agonist withdrawal and possible predictive factors of recurrence in prolactinomas.
    Sala E; Bellaviti Buttoni P; Malchiodi E; Verrua E; Carosi G; Profka E; Rodari G; Filopanti M; Ferrante E; Spada A; Mantovani G
    J Endocrinol Invest; 2016 Dec; 39(12):1377-1382. PubMed ID: 27245604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.